- Home
- COTY vs NUVL Comparison
COTY vs NUVL Comparison
Compare COTY & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COTY
- NUVL
- Stock Information
- Founded
- COTY 1904
- NUVL 2017
- Country
- COTY United States
- NUVL United States
- Employees
- COTY N/A
- NUVL N/A
- Industry
- COTY Package Goods/Cosmetics
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- COTY Consumer Discretionary
- NUVL Health Care
- Exchange
- COTY Nasdaq
- NUVL Nasdaq
- Market Cap
- COTY 5.8B
- NUVL 5.6B
- IPO Year
- COTY 2013
- NUVL 2021
- Fundamental
- Price
- COTY $4.78
- NUVL $75.00
- Analyst Decision
- COTY Buy
- NUVL Strong Buy
- Analyst Count
- COTY 15
- NUVL 8
- Target Price
- COTY $7.43
- NUVL $115.50
- AVG Volume (30 Days)
- COTY 9.3M
- NUVL 452.9K
- Earning Date
- COTY 08-19-2025
- NUVL 08-07-2025
- Dividend Yield
- COTY N/A
- NUVL N/A
- EPS Growth
- COTY N/A
- NUVL N/A
- EPS
- COTY N/A
- NUVL N/A
- Revenue
- COTY $6,003,900,000.00
- NUVL N/A
- Revenue This Year
- COTY N/A
- NUVL N/A
- Revenue Next Year
- COTY $1.19
- NUVL N/A
- P/E Ratio
- COTY N/A
- NUVL N/A
- Revenue Growth
- COTY N/A
- NUVL N/A
- 52 Week Low
- COTY $4.46
- NUVL $55.54
- 52 Week High
- COTY $10.54
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- COTY 44.20
- NUVL 48.73
- Support Level
- COTY $4.73
- NUVL $76.42
- Resistance Level
- COTY $5.34
- NUVL $78.94
- Average True Range (ATR)
- COTY 0.20
- NUVL 2.71
- MACD
- COTY -0.01
- NUVL -0.34
- Stochastic Oscillator
- COTY 7.38
- NUVL 31.73
About COTY Coty Inc.
Coty is a global beauty maker that focuses on fragrance (59% of sales) and color cosmetics (28%), with limited exposure to skincare (5%) and body care (8%). For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein, while its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrities Kim Kardashian and Kylie Jenner to launch makeup products bearing their names. By region, Coty generates close to 44% of sales from Europe, 42% from the Americas, and 14% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 53% stake.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.